Rang	Name	Position
1	Dr. Frederick G. Vogt Esq., J.D., Ph.D.	Interim CEO, President, General Counsel, Corporate Secretary & Director
2	Ms. Corleen M. Roche	Chief Financial Officer
3	Dr. Igor P. Bilinsky Ph.D.	Chief Operating Officer
4	Dr. Raj K. Puri M.D., Ph.D.	Chief Regulatory Officer
5	Mr. Daniel G. Kirby	Chief Commercial Officer
6	Ms. Sara Pellegrino	Senior Vice President of Investor Relations & Corporate Communications
7	Ms. Tracy Winton	Executive Vice President of Human Resources
8	Mr. Howard B. Johnson M.B.A.	Chief Business Officer
9	Mr. Kevin Smyth	Executive Vice President of Quality
10	Dr. Brian Gastman M.D.	Executive Vice President of Translational Medicine & Research

Aufteilung der Investoren

Rang	Inhaber	Anteile	Wert
1	BlackRock Inc	8,16%	0,55 Mrd. USD
2	Mhr Fund Management Llc	6,39%	0,43 Mrd. USD
3	State Street Corp	5,40%	0,36 Mrd. USD
4	Two Sigma Investments LLC	4,20%	0,28 Mrd. USD
5	Vanguard Capital Management, LLC	4,02%	0,27 Mrd. USD
6	Vanguard Portfolio Management, LLC	3,18%	0,21 Mrd. USD
7	Geode Capital Management, LLC	2,28%	0,15 Mrd. USD
8	Millennium Management LLC	1,88%	0,13 Mrd. USD
9	Dimensional Fund Advisors, Inc.	1,43%	0,10 Mrd. USD
10	Palo Alto Investors, LLC	1,17%	0,08 Mrd. USD
11	The Goldman Sachs Group Inc	1,13%	0,08 Mrd. USD
12	Nuveen, LLC	1,10%	0,07 Mrd. USD
13	Bank of America Corp	1,10%	0,07 Mrd. USD
14	Morgan Stanley - Brokerage Accounts	1,10%	0,07 Mrd. USD
15	Jupiter Asset Management Limited	1,00%	0,07 Mrd. USD
16	Jane Street Group LLC	0,97%	0,07 Mrd. USD
17	Northern Trust Corp	0,92%	0,06 Mrd. USD
18	AQR Capital Management LLC	0,85%	0,06 Mrd. USD
19	Wells Fargo & Co	0,72%	0,05 Mrd. USD
20	Charles Schwab Investment Management Inc	0,71%	0,05 Mrd. USD